Elevai Labs Inc
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ELEVAI LABS INC. | |
| By: | /s/ Jordan R. Plews |
| Jordan R. Plews | |
| Chief Executive Officer | |
| (Principal Executive Officer) | |
| By: | /s/ Graydon Bensler |
| Graydon Bensler | |
| Chief Financial Officer | |
| (Principal Accounting Officer) |
Each person whose signature appears below constitutes and appoints Jordan R. Plews and Graydon Bensler, jointly and severally, his or her attorney-in-fact, with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Capacity | Date |
|---|---|---|
| /s/ Jordan R. Plews | Chief Executive Officer, President and Director | March 29, 2024 |
| Jordan R. Plews | (Principal Executive Officer) | |
| /s/ Graydon Bensler | Chief Financial Officer and Director | March 29, 2024 |
| Graydon Bensler | (Principal Accounting Officer) | |
| /s/ Hatem (Tim) Abou-Sayed | Director | March 29, 2024 |
| Hatem (Tim) Abou-Sayed | ||
| /s/ Jeffrey Parry | Director | March 29, 2024 |
| Jeffrey Parry | ||
| /s/ Juliana Daley | Director | March 29, 2024 |
| Juliana Daley | ||
| /s/ George Kovalyov | Director | March 29, 2024 |
| George Kovalyov | ||
INDEX TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
| Page | |
| Consolidated Financial Statements | |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID 6706) | F-3 |
| Consolidated Balance Sheets as of December 31, 2023 and 2022 | F-4 |
| Consolidated and Combined Statements of Operations and Comprehensive Loss for the years ended December 31, 2023 and 2022 | F-5 |
| Consolidated and Combined Statements of Changes in Equity for the years ended December 31, 2023 and 2022 | F-6 |
| Consolidated and Combined Statements of Cash Flows for the years ended December 31, 2023 and 2022 | F-7 |
| Notes to the Consolidated and Combined Financial Statements | F-8 |
Consolidated Financial Statements of
**For the years ended
December 31, 2023 and 2022
(Expressed in United States Dollars)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.